Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study

Open Access

Peer-reviewed

Research Article

Arto A. Palmu ,

* E-mail: arto.palmu@thl.fi

Affiliation Department of Public Health Solutions, National Institute for Health and Welfare, Tampere, Finland
⨯
Hanna Rinta-Kokko,

Affiliation Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland
⨯
Hanna Nohynek,

Affiliation Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland
⨯
J. Pekka Nuorti,

Affiliation Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland
⨯
Terhi M. Kilpi,

Affiliation Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland
⨯
Jukka Jokinen

Affiliation Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland
⨯

Reader Comments (0)

Pneumonia
Is the Subject Area "Pneumonia" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Children
Is the Subject Area "Children" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.
Finland
Is the Subject Area "Finland" applicable to this article?

Thanks for your feedback.
Influenza
Is the Subject Area "Influenza" applicable to this article?

Thanks for your feedback.